What is CO2 Gro Inc?
, together with its subsidiaries, focuses on commercializing patent-licensed CO2 gas infusion technology and patent-pending US PTO CO2 delivery solutions system.
BLONF · Verdict
Moderate reward · elevated risk
BLONF stands out on balance sheet and growth, but watch the volatility signal.
Based on 88% data coverage
BLONF · Verdict
Current ratio 3.12
Rev +194.6% CAGR · earnings +6.2%
Weak vs peers
-467% free-cash-flow margin
-620% net margin · -164% ROE
Model-based scoring. For information only — not financial advice.
, together with its subsidiaries, focuses on commercializing patent-licensed CO2 gas infusion technology and patent-pending US PTO CO2 delivery solutions system. The company operates in the United states and Canada. The company is listed on the PINK in USA, operating in the Basic Materials sector, with a market capitalisation of 194.65K.
The scoring profile indicates limited reward potential at this time, with growth and valuation offering the most support. Risk indicators are elevated — volatility and macro sensitivity warrant consideration.
For informational purposes only. Not financial advice.